{"disease":{"id":"recurrent-angioedema","name":"recurrent angioedema"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03749135","title":"Dupilumab in Chronic Spontaneous Urticaria","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}